THCA vs CBGA: How the Two Acids Relate

Every bit of THCA in a jar of hemp flower started life as CBGA. The plant builds CBGA first, and an enzyme, THCA synthase, reshapes it into THCA. Raw, both acids are non-intoxicating. Heat is where their paths split: decarboxylated CBGA becomes CBG, which stays that way, while THCA becomes THC, the one that gets people high. Established

That fork decides most of what matters about the pair in trade: how a lab arrives at a total-THC figure, whether a product trips a drug test, and which side of the hemp line it lands on. The chemistry is well mapped. What either acid does in a human body is still an open question.

Every statement below is graded by the evidence behind it. Legal notes are general, dated and not legal advice; this page makes no therapeutic claim for either compound.

Side by side

Attribute	THCA — tetrahydrocannabinolic acid	CBGA — cannabigerolic acid
Where it sits	THCA — tetrahydrocannabinolic acidDownstream of CBGA, made from it by THCA synthase (Sirikantaramas 2004) · Established	CBGA — cannabigerolic acidUpstream: the first acid the plant builds, which synthases then convert into THCA, CBDA and CBCA (Zirpel 2018) · Demonstrated · plant biochemistry
Intoxicating as a raw acid?	THCA — tetrahydrocannabinolic acidNo · Established	CBGA — cannabigerolic acidNo · Established
What heat makes of it	THCA — tetrahydrocannabinolic acidIntoxicating Δ⁹-THC · Established	CBGA — cannabigerolic acidNon-intoxicating CBG · Established
Decarboxylation	THCA — tetrahydrocannabinolic acidConverts with almost any heat; total-THC figures multiply THCA by 0.877	CBGA — cannabigerolic acidNeeds roughly 110–130 °C and converts less efficiently than THCA (Wang 2016) · Demonstrated
Molecular formula	THCA — tetrahydrocannabinolic acidC₂₂H₃₀O₄ (≈358.48 g/mol)	CBGA — cannabigerolic acidC₂₂H₃₂O₄ (≈360.49 g/mol; CAS 25555-57-1)
Drug testing	THCA — tetrahydrocannabinolic acidA genuine risk, because THCA products readily deliver THC · Established	CBGA — cannabigerolic acidStandard tests do not target it, though raw or full-spectrum products may carry trace THC or THCA · Established
Human evidence	THCA — tetrahydrocannabinolic acidNo study of THCA's own effects is in our registry yet · Catalogue in progress	CBGA — cannabigerolic acidNo verified human evidence of any health effect · No primary evidence
US legal status (general, dated; not legal advice)	THCA — tetrahydrocannabinolic acidTurns on the test applied: delta-9 only, or total THC	CBGA — cannabigerolic acidHemp-derived material is generally legal at ≤0.3% Δ⁹-THC; rules vary by jurisdiction and product type

Figure P · targets side by side

THCA and CBGa at six targets: what our registry records, and where it records nothing

How to read a cell: An oxblood ring holds the direction: a bar: blocks; a chevron: activates; a chevron with a bar: activates, then desensitises; two bars: damps activation. A gold ring with a dot: recorded in a review, direction qualified by the source, no rung of its own. A dashed frame: no graded interaction in our registry.
CB1 cannabinoid receptor: THCA: no graded interaction in our registry. CBGa: no graded interaction in our registry.
CB2 cannabinoid receptor: THCA: no graded interaction in our registry. CBGa: no graded interaction in our registry.
α2-adrenoceptor: THCA: no graded interaction in our registry. CBGa: no graded interaction in our registry.
5-HT1A serotonin receptor: THCA: no graded interaction in our registry. CBGa: no graded interaction in our registry.
TRPV1 and TRPV2 ion channels: THCA: no graded interaction in our registry. CBGa: no graded interaction in our registry.
TRPM8 ion channel: THCA: no graded interaction in our registry. CBGa: no graded interaction in our registry.

A dashed frame means the registry holds no graded interaction there, which is not the same as evidence of none. None of this is an effect in people, and none of it is a dose. THCA and CBGa have no receptor-level record in our registry at any of the six targets: the registry is CBG-centred, and the empty column says so. CBG's record at researcher depth is on the monograph's target map; the receptors themselves are drawn on the ECS map →

The settled facts

Start with the plant, because everything a buyer or a lab cares about follows from what happens inside it.

A single enzyme connects them. THCA synthase turns CBGA into THCA and commits that material to the THC branch (Sirikantaramas 2004). Established
CBGA feeds three branches. Plant synthases make THCA, CBDA and CBCA from CBGA. All three are a little sloppy, and each also turns out some CBCA (Zirpel 2018). Demonstrated · plant biochemistry
Heat decides what you get. Decarboxylation yields non-intoxicating CBG from CBGA and intoxicating Δ⁹-THC from THCA. Established
CBGA is the stubborn one. It decarboxylates at roughly 110–130 °C and converts less efficiently than THCA does (Wang 2016). Demonstrated
The human record is blank on both sides. Our registry holds no study of what THCA does on its own, and CBGA has no verified human evidence of a health effect. Neither has been tested in people, and untested is a different verdict from failed. No primary evidence

Common questions

Is CBGA the same as THCA?

No: CBGA is the parent acid, and THCA is one of its offspring. The plant makes CBGA first, then THCA synthase converts some of it into THCA, the acid on the THC branch. The formulas differ (C₂₂H₃₂O₄ and C₂₂H₃₀O₄), and so do the neutral forms heat turns them into, CBG on one side and THC on the other. Established

Do THCA or CBGA get you high?

Raw, neither one gets you high. Heat is what changes the answer, and only for one of them: THCA becomes intoxicating Δ⁹-THC, while CBGA becomes CBG and stays clear-headed company. Established

Does CBGA turn into THCA?

Inside the living plant, yes: THCA synthase makes THCA from CBGA (Sirikantaramas 2004). Outside it, the route closes. Heat a CBGA-rich extract and you get CBG, never THCA or THC. Established

Will THCA or CBGA show up on a drug test?

THCA may well show up; CBGA itself sits outside what standard tests look for. THCA products readily deliver THC, and some lab methods detect THCA directly. CBGA's clean record with the tests is less comforting than it sounds, because raw or full-spectrum hemp products that contain it can also carry trace THC or THCA. What a test sees is the whole product, whatever cannabinoid the label leads with. Established

Is there human evidence for THCA or CBGA?

No, not for the effects of either compound itself. Our registry holds no study of what THCA does on its own, and no verified human clinical evidence establishes a health effect for CBGA. Both are untested rather than tested and failed, and any health promise attached to either acid is running ahead of the science. (Not medical advice.) No primary evidence

Informational only — not our claims, and not advice. The statements on this page about potential effects, benefits, or uses reflect claims made by third parties (manufacturers, media, traditional use, or preliminary research) and are presented for educational and informational purposes only. CBG Atlas does not make, adopt, endorse, or affirm these claims, and does not represent them as fact. These statements have not been evaluated by the Food and Drug Administration (or any regulator) and are not intended to diagnose, treat, cure, or prevent any disease. Nothing here is medical, legal, or professional advice; cannabinoid effects, safety, and legal status vary by person, product, and jurisdiction and can change over time. Consult a qualified professional before making any health or purchasing decision. Where we can, we show how strong the evidence is and cite the source; where evidence is thin or absent, we say so. Peregrine Biopharma funds the platform and holds no editorial authority.

Sources

Sirikantaramas et al. (2004). The gene controlling marijuana psychoactivity: molecular cloning and heterologous expression of Delta1-tetrahydrocannabinolic acid synthase from Cannabis sativa L. J Biol Chem. PMID 15190053.
Zirpel et al. (2018). Elucidation of structure-function relationship of THCA and CBDA synthase from Cannabis sativaL. J Biotechnol. PMID 30053500.
Wang et al. (2016). Decarboxylation Study of Acidic Cannabinoids: A Novel Approach Using Ultra-High-Performance Supercritical Fluid Chromatography/Photodiode Array-Mass Spectrometry. Cannabis Cannabinoid Res. PMID 28861498.

Before you act on what you have read

Informational only, not medical advice. CBG Atlas is a scientific reference. Nothing here diagnoses, treats, cures or prevents any disease. Every claim on the page carries the grade of the evidence behind it, and the grade sets the words the claim may use. How we grade evidence.

Each grade rates the support for a claim across the literature. It does not rate any single study. An effect in cells may never show up in people. The grades cover the studies checked up to 9 August 2026. This page is for information and is not medical advice.

Cardiovascular note. CBG is a potent α2-adrenoceptor agonist in vitro, and α2 agonism can lower blood pressure. Anyone taking blood-pressure or other cardiovascular medication should consult a clinician before use. This is educational information, not medical advice.

Funding and independence. Peregrine Biopharma funds the platform and holds no editorial authority.

Report a safety event →

Keep exploring

The compounds compared

More comparisons

All comparisons

Reference